Pharma GMP News of the Week: 24-April-2022

Period: April 17, 2022 to April 23, 2022

The HAD (Healthcare Distribution Alliance) issued guideline to support pharma industry for placement of bar code labels on their products to meet the Drug Supply Chain Security Act (DSCSA)

Date of issue: April 18, 2022

Source: https://www.hda.org/resources/2022-guidelines-for-bar-coding-in-the-pharmaceutical-supply-chain

FDA published final guidance on “Drug Products, Including Biological Products, that Contain Nanomaterials – Guidance for Industry”

Date of issue: April 21, 2022

The objective of this guideline is provides guidance on the product development such as biological products having a nanomaterial in the finished dosage form.

The objective on nanomaterials in drug product may be different depending on the functionality. It could be active ingredients, carriers loaded with an active ingredient or inactive ingredients.

Source: https://www.fda.gov/media/157812/download

Scroll to Top